Research statistics
Petrelintide research: publications and trials
At a glance
Publications, all years
8
Since 2025
Publications in 2026 so far
6
Through November 15, 2026
Human clinical research
25.0%
2 of 8 classified
Registered clinical trials
12
ClinicalTrials.gov
Randomized controlled trials
2
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
25.0%
1 animal · 1 in vitro · 0 computational
Records that only mention it
1
Not counted above
Status in the library: In clinical trials. Groups: Amylin analogues.
What to keep in mind
- Fewer than three randomized controlled trials are indexed.
- Fewer than 25 publications are indexed, so year-to-year changes are not meaningful.
- Some completed trials have neither posted results nor a linked results publication.
Publications by year
Petrelintide publications by year and evidence
Show the data
| Year | Human clinical research | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|---|
| 2025 | 0 | 2 | 0 | 0 | 2 |
| 2026 (to date) | 2 | 0 | 3 | 1 | 6 |
Study types
| Review | 3 |
|---|---|
| Randomized controlled trial | 2 |
| Animal study | 1 |
| In vitro study | 1 |
| Editorial, letter or other | 1 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Obesity and weight management | 6 |
|---|---|
| Metabolic health | 3 |
| Endocrinology | 1 |
Registered clinical trials
2 of 3 trials completed at least a year before the cutoff have neither posted results nor a linked results publication. A registration is not a result.
Completed: 6 · Recruiting: 5 · Not yet recruiting: 1
Phase 1: 5 · Phase 2: 4 · Phase 3: 3
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
- Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial.
The lancet. Diabetes & endocrinology · September 29, 2026 · Randomized controlled trial · cited 0 times
PMID 42810355 · DOI 10.1016/s2213-8587(26)00213-5 · Human clinical research
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.
Diabetes, obesity & metabolism · April 22, 2026 · Randomized controlled trial · cited 3 times · open access
PMID 42017294 · DOI 10.1111/dom.70753 · Human clinical research
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue.
Journal of medicinal chemistry · November 11, 2025 · Animal study · cited 14 times · open access
PMID 41217931 · DOI 10.1021/acs.jmedchem.5c01185 · Animal studies
- Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment.
Journal of medicinal chemistry · July 3, 2025 · In vitro study · cited 8 times
PMID 40608546 · DOI 10.1021/acs.jmedchem.5c01120 · In vitro studies
- Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes.
Peptides · February 24, 2026 · Review · cited 6 times · open access
PMID 41747885 · DOI 10.1016/j.peptides.2026.171480 · Reviews and meta-analyses
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.
Diabetes, obesity & metabolism · April 22, 2026 · Randomized controlled trial · cited 3 times · open access
PMID 42017294 · DOI 10.1111/dom.70753 · Human clinical research
- Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.
Diabetes, obesity & metabolism · July 14, 2026 · Review · cited 1 times · open access
PMID 42452898 · DOI 10.1111/dom.71074 · Reviews and meta-analyses
Latest publications
- Petrelintide and the evolving role of amylin agonism in obesity.
The lancet. Diabetes & endocrinology · September 29, 2026 · Editorial, letter or other · cited 0 times
PMID 42810353 · DOI 10.1016/s2213-8587(26)00216-0 · Commentary and other
- Petrelintide, a human amylin analogue for the treatment of obesity (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial.
The lancet. Diabetes & endocrinology · September 29, 2026 · Randomized controlled trial · cited 0 times
PMID 42810355 · DOI 10.1016/s2213-8587(26)00213-5 · Human clinical research
- Beyond GLP-1: Amylin-based pharmacotherapy and the search for better-tolerated weight-loss drugs.
Pharmacological research · August 12, 2026 · Review · cited 0 times · open access
PMID 42586227 · DOI 10.1016/j.phrs.2026.108382 · Reviews and meta-analyses
- Amylin Analogs: The Next Major Class of Weight Loss Therapy: A Review of Experimental Data and Early-Phase Clinical Trials.
Diabetes, obesity & metabolism · July 14, 2026 · Review · cited 1 times · open access
PMID 42452898 · DOI 10.1111/dom.71074 · Reviews and meta-analyses
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials.
Diabetes, obesity & metabolism · April 22, 2026 · Randomized controlled trial · cited 3 times · open access
PMID 42017294 · DOI 10.1111/dom.70753 · Human clinical research
- Long-acting amylin-related peptides as therapies for obesity and type 2 diabetes.
Peptides · February 24, 2026 · Review · cited 6 times · open access
PMID 41747885 · DOI 10.1016/j.peptides.2026.171480 · Reviews and meta-analyses
- Development of Petrelintide: a Potent, Stable, Long-Acting Human Amylin Analogue.
Journal of medicinal chemistry · November 11, 2025 · Animal study · cited 14 times · open access
PMID 41217931 · DOI 10.1021/acs.jmedchem.5c01185 · Animal studies
- Discovery of BGM1812, a Novel Dual Amylin and Calcitonin Receptor Agonist for Obesity Treatment.
Journal of medicinal chemistry · July 3, 2025 · In vitro study · cited 8 times
PMID 40608546 · DOI 10.1021/acs.jmedchem.5c01120 · In vitro studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: Petrelintide; ZP8396
((TITLE_ABS:"Petrelintide" OR CHEM:"Petrelintide") OR (TITLE_ABS:"ZP8396" OR CHEM:"ZP8396" OR TITLE_ABS:"ZP 8396" OR CHEM:"ZP 8396")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Petrelintide research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/petrelintide